Evidence map›Paper›PMID 42642371›Full record

ArticleNature communications2026

Ultrasensitive detection of lung inflammation in male mice using immuno-magnetic particle imaging.

Swannie Pedron, Sara Martinez de Lizarrondo, Laurent D'Arco, Jolan Malherbe, Sophie Trébel, Jurie Tashkandi, Karen Alt, Bertrand Galy, Pierre-Simon Bellaye, Jonathan Vigne and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Swannie Pedron *Normandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France.
Sara Martinez de Lizarrondo *Normandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France.
Laurent D'ArcoNormandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France.
Jolan MalherbeNormandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France.ORCID http://orcid.org/0000-0002-9355-0428
Sophie TrébelNormandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France.
Jurie TashkandiNanoTheranostics Laboratory, Diabetes Department, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.ORCID http://orcid.org/0009-0000-1979-0442
Karen AltNanoTheranostics Laboratory, Diabetes Department, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-6252-1931
Bertrand GalyDepartment of Nuclear Medicine, Caen-Normandie University Hospital, CHU, Caen, France.
Pierre-Simon BellayeUniversité Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, IMATHERA, UMR INSERM 1231, HSP-Pathies Team, Dijon, France.
Jonathan VigneNormandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France.ORCID http://orcid.org/0000-0002-6575-9224
Denis VivienNormandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France.ORCID http://orcid.org/0000-0002-7636-2185
Maxime Gauberti *Normandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France. gauberti@cyceron.fr.ORCID http://orcid.org/0000-0003-0752-7342
Thomas Bonnard *Normandie University, UNICAEN, INSERM UMR-S 1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Brain Blood & Memory at Caen Normandie Institute (BBM@C), Caen, France. bonnard@cyceron.fr.ORCID http://orcid.org/0000-0003-0412-8223

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Timely and sensitive detection of inflammatory and infectious lung diseases remains a major clinical challenge. Current diagnostic approaches often identify pathology only at advanced stages, leaving gaps in acute triage, fibrotic activity assessment, transplant rejection monitoring and inflammation follow-up. Magnetic Particle Imaging (MPI) offers a sensitive, background-free, whole-body imaging modality without ionizing radiation. Here, we present immuno-Magnetic Particle Imaging (immuno-MPI) using micron-sized iron oxide particles targeted to VCAM-1, a key marker of endothelial inflammation. In three lung inflammation models in male mice, MPIO@αVCAM-1 generates high-contrast images within 3 minutes following intravenous injection at 1 mg/kg, with rapid accumulation at the inflamed endothelium and fast clearance of unbound particles. Predominantly confined to the vasculature, these particles selectively target VCAM-1 and discriminate inflamed from healthy lungs at doses as low as 0.18 mg/kg (7.5 µg iron). Specificity for VCAM-1 is confirmed by the absence of signal using control antibodies (MPIO@IgG) and competitive blocking with free αVCAM-1 antibodies. Overall, immuno-MPI provides a non-invasive approach that avoids ionizing radiation and supports pulmonary inflammation monitoring.

Indexed as

Magnetic Particle ImagingPneumoniaAnimalsDisease Models, AnimalFerric CompoundsLungMaleMiceMice, Inbred C57BLVascular Cell Adhesion Molecule-1Ferric Compoundsferric oxideVascular Cell Adhesion Molecule-1

Identifiers

PMID42642371
PMCPMC13507048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.